The Mosaic Company

MOS
Sector

Materials

Industry

Agricultural Inputs

Market Cap

$8.07B

Employees

14K

Company Overview

The Mosaic Company, through its subsidiaries, produces and markets concentrated phosphate and potash crop nutrients in North America and internationally. The company operates through three segments: Phosphates, Potash, and Mosaic Fertilizantes. It owns and operates mines, which produce concentrated phosphate crop nutrients, such as diammonium phosphate, monoammonium phosphate, and ammoniated phosphate products; and phosphate-based animal feed ingredients primarily under the Biofos and Nexfos brand names, as well as produces a double sulfate of potash magnesia product under K-Mag brand name. The company also produces and sells potash for use in the manufacturing of mixed crop nutrients and animal feed ingredients, and for industrial use; and for use in the de-icing and as a water softener regenerant. In addition, it provides nitrogen-based crop nutrients, animal feed ingredients, and other ancillary services; and purchases and sells phosphates, potash, and nitrogen products. The company sells its products to wholesale distributors, retail chains, farmers, cooperatives, independent retailers, and national accounts. The company was incorporated in 2004 and is headquartered in Tampa, Florida.

Filing Highlights

Key insights and themes extracted from this filing

10 Themes

Financial Performance

3 Insights

Net earnings attributable to Mosaic surged to $238.1 million ($0.75 diluted EPS) for Q1 2025, a substantial increase from $45.2 million ($0.14 diluted EPS) in Q1 2024. This dramatic improvement reflects a strong recovery in profitability.

Despite a 2% year-over-year decrease in net sales to $2,620.9 million, gross margin improved by 22% to $488.4 million in Q1 2025, increasing the gross margin percentage from 15% to 19%. This indicates effective cost management and favorable pricing dynamics in key segments.

A significant foreign currency transaction gain of $133.1 million in Q1 2025 (compared to a $100.3 million loss in Q1 2024) positively impacted earnings. However, this was largely offset by a $117 million unrealized mark-to-market loss on the investment in Ma'aden shares, categorized under other expense.

Growth & Strategy

3 Insights

Management Execution

3 Insights

Risk Factors

3 Insights

Competitive Position

3 Insights

Operational Efficiency

3 Insights

Innovation & Technology

3 Insights

Capital Allocation

3 Insights

ESG initiatives

3 Insights

Market Environment

3 Insights